Clinical Trial Update: Home-based Intervention With Semaglutide Treatment Of Neuroleptica-Related Prediabetes [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating home-based semaglutide for neuroleptic-induced prediabetes in people with schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prediabetes
• Schizophrenia

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Jan Frystyk | Conditions: Schizophrenia, Prediabetic State | Phase 2 | Status: COMPLETED